- Home
- TLN vs WAT Comparison
TLN vs WAT Comparison
Compare TLN & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLN | WAT |
|---|---|---|
| Founded | 2015 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.6B | 17.4B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | TLN | WAT |
|---|---|---|
| Price | $354.02 | $394.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | ★ $415.38 | $382.14 |
| AVG Volume (30 Days) | ★ 900.2K | 531.7K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.82 |
| EPS | 4.55 | ★ 10.88 |
| Revenue | $2,343,000,000.00 | ★ $3,105,638,000.00 |
| Revenue This Year | $13.07 | $7.96 |
| Revenue Next Year | $73.72 | $6.32 |
| P/E Ratio | $77.79 | ★ $36.30 |
| Revenue Growth | ★ 16.22 | 6.90 |
| 52 Week Low | $158.08 | $275.05 |
| 52 Week High | $451.28 | $423.56 |
Technical Indicators
Market Signals| Indicator | TLN | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 38.89 | 61.33 |
| Support Level | $359.52 | $386.09 |
| Resistance Level | $377.08 | $403.80 |
| Average True Range (ATR) | 18.51 | 9.63 |
| MACD | -1.00 | -1.66 |
| Stochastic Oscillator | 11.31 | 53.55 |
Price Performance
Historical ComparisonAbout TLN Talen Energy Corporation Common Stock
Talen Energy Corp is an independent power producer and energy infrastructure company. The company owns and operates approximately 10.7 gigawatts of power infrastructure in the United States. The group produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, including PJM and WECC, with its generation fleet located in the Mid-Atlantic and Montana.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.